Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC31859778;9779;9780 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256
N2AB31859778;9779;9780 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256
N2A31859778;9779;9780 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256
N2B31399640;9641;9642 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256
Novex-131399640;9641;9642 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256
Novex-231399640;9641;9642 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256
Novex-331859778;9779;9780 chr2:178766531;178766530;178766529chr2:179631258;179631257;179631256

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Ig-22
  • Domain position: 39
  • Structural Position: 56
  • Q(SASA): 0.5427
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K None None 0.992 D 0.575 0.461 0.442567846599 gnomAD-4.0.0 1.5906E-06 None None None None N None 0 0 None 0 2.77439E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.3896 ambiguous 0.3645 ambiguous -0.781 Destabilizing 0.996 D 0.64 neutral D 0.568976434 None None N
E/C 0.9756 likely_pathogenic 0.9733 pathogenic -0.52 Destabilizing 1.0 D 0.715 prob.delet. None None None None N
E/D 0.6903 likely_pathogenic 0.6202 pathogenic -0.738 Destabilizing 0.996 D 0.494 neutral D 0.591007689 None None N
E/F 0.9753 likely_pathogenic 0.9766 pathogenic -0.116 Destabilizing 1.0 D 0.711 prob.delet. None None None None N
E/G 0.7034 likely_pathogenic 0.7063 pathogenic -1.096 Destabilizing 0.999 D 0.647 neutral D 0.637129084 None None N
E/H 0.9046 likely_pathogenic 0.8963 pathogenic 0.006 Stabilizing 1.0 D 0.703 prob.neutral None None None None N
E/I 0.7641 likely_pathogenic 0.7792 pathogenic 0.07 Stabilizing 1.0 D 0.735 prob.delet. None None None None N
E/K 0.4347 ambiguous 0.4361 ambiguous -0.349 Destabilizing 0.992 D 0.575 neutral D 0.548472214 None None N
E/L 0.7263 likely_pathogenic 0.7221 pathogenic 0.07 Stabilizing 1.0 D 0.722 prob.delet. None None None None N
E/M 0.7643 likely_pathogenic 0.7867 pathogenic 0.239 Stabilizing 1.0 D 0.688 prob.neutral None None None None N
E/N 0.8219 likely_pathogenic 0.7969 pathogenic -0.923 Destabilizing 1.0 D 0.717 prob.delet. None None None None N
E/P 0.7378 likely_pathogenic 0.6827 pathogenic -0.194 Destabilizing 1.0 D 0.753 deleterious None None None None N
E/Q 0.3343 likely_benign 0.3243 benign -0.803 Destabilizing 0.957 D 0.283 neutral N 0.501827228 None None N
E/R 0.6548 likely_pathogenic 0.6407 pathogenic 0.099 Stabilizing 0.999 D 0.715 prob.delet. None None None None N
E/S 0.6693 likely_pathogenic 0.6456 pathogenic -1.157 Destabilizing 0.997 D 0.655 neutral None None None None N
E/T 0.7073 likely_pathogenic 0.6952 pathogenic -0.89 Destabilizing 1.0 D 0.729 prob.delet. None None None None N
E/V 0.5708 likely_pathogenic 0.5821 pathogenic -0.194 Destabilizing 0.999 D 0.717 prob.delet. D 0.541029134 None None N
E/W 0.9935 likely_pathogenic 0.9942 pathogenic 0.203 Stabilizing 1.0 D 0.717 prob.delet. None None None None N
E/Y 0.9643 likely_pathogenic 0.9646 pathogenic 0.149 Stabilizing 1.0 D 0.723 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.